
There is a duty to ensure access to innovative treatments for patients with unmet need, but a health service gatekeeper …

In often tough regulatory climates and with threats to public health are growing in sceptical corners of society, the need …

The FDA has announced its intention to incorporate real-world data elements to a greater degree into its regulatory decision-making framework …

A new report has canvassed the intentions of industry players in the use of real world data and evidence over …

Following on from this week’s earlier piece on real world evidence, Jacqueline Corrigan-Curay, Director of CDER’s Office of Medical Policy at the FDA, …

Rising demands on the industry has pharma firms calling for a more-effective, fit-for-purpose methodology for generating clinical data. Could the …

The real-world study of AstraZeneca’s diabetes drug Forxiga has found its use in UK patients primary care patients supports the …

What do you believe? Are you a doubting Thomas, always wanting to have the pragmatic proof personally presented to you, …